Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Raynaud's phenomenon].

S Zeni1, F Ingegnoli

  • 1Dipartimento e Cattedra di Reumatologia dell'Università degli Studi, AO Istituto Ortopedico Gaetano Pini, Milano, Italy. zeni@gpini.it

Reumatismo
|August 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease disclosure in the workplace in people living with rheumatic diseases: an exploratory study.

Reumatismo·2024
Same author

Nailfold capillaroscopy in the rheumatological current clinical practice in Italy: results of a national survey.

Reumatismo·2022
Same author

Is there really room for anti-rheumatic drugs in the treatment of COVID-19?

Scandinavian journal of rheumatology·2020
Same author

Translation and cross-cultural adaptation into Italian of the self-administered FLARE-RA questionnaire for rheumatoid arthritis.

Reumatismo·2020
Same author

Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens.

Reumatismo·2019
Same author

Smac127 Has Proapoptotic and Anti-Inflammatory Effects on Rheumatoid Arthritis Fibroblast-Like Synoviocytes.

Mediators of inflammation·2016
Same journal

Delayed referral, socioeconomic status, and disease characteristics as factors associated with disabilities in rheumatoid arthritis patients: a multicenter observational study.

Reumatismo·2026
Same journal

Telerheumatology to improve first access outcomes in outpatients: a prospective monocentric pilot study.

Reumatismo·2026
Same journal

Hypocomplementemic urticarial vasculitis: a rare presentation revealing systemic lupus erythematosus and Sjögren's disease.

Reumatismo·2026
Same journal

Is there still someone laughing at Christopher Columbus?

Reumatismo·2026
Same journal

Concurrent herpetic hypertensive anterior uveitis and cytomegalovirus retinitis in a non-HIV patient with melanoma differentiation-associated gene-5 dermatomyositis: intravenous immunoglobulin comes to the rescue.

Reumatismo·2026
Same journal

Myasthenic syndrome in systemic lupus erythematosus successfully treated with plasma exchange: through one of the unexplored faces of neuropsychiatric involvement.

Reumatismo·2026
See all related articles

Raynaud's phenomenon (RP) is a vasospastic disorder causing episodic color changes in extremities due to cold or stress. Differentiating primary from secondary RP and managing triggers like smoking are key for patient care.

Area of Science:

  • Vascular Medicine
  • Rheumatology
  • Dermatology

Context:

  • Raynaud's phenomenon (RP) affects extremities with episodic color changes (blanching, cyanosis, hyperemia) triggered by cold or stress.
  • Prevalence varies globally, with higher incidence in women, and RP can be primary or secondary to connective tissue diseases (CTDs).
  • Distinguishing RP from acrocyanosis and identifying secondary causes through comprehensive patient evaluation is crucial.

Purpose:

  • To define Raynaud's phenomenon (RP) and outline diagnostic criteria for primary and secondary forms.
  • To highlight the association of secondary RP with connective tissue diseases, particularly systemic sclerosis.
  • To emphasize the importance of patient history, physical examination, and specific tests in diagnosing RP.

Summary:

Related Experiment Videos

  • Primary RP criteria include symmetric attacks, absence of tissue damage, negative autoantibodies, and normal nailfold capillaroscopy.
  • Secondary RP presents with older age of onset, asymmetric attacks, ischemic lesions, positive autoantibodies, and potential CTD features.
  • Management involves lifestyle changes (smoking cessation, temperature avoidance) and pharmacotherapy, including calcium-channel blockers, with prostaglandins for severe cases.

    • Impact:

    • Provides a framework for differentiating primary and secondary Raynaud's phenomenon, guiding appropriate diagnostic and management strategies.
    • Emphasizes the link between RP and underlying systemic conditions, promoting early detection of connective tissue diseases.
    • Informs clinical practice on essential diagnostic steps and therapeutic options for Raynaud's phenomenon, from lifestyle modifications to advanced treatments.